[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Corrales et al., 2011 - Google Patents

Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome

Corrales et al., 2011

View HTML
Document ID
8312086460319021401
Author
Corrales R
Narayanan S
Fernández I
Mayo A
Galarreta D
Fuentes-Páez G
Chaves F
Herreras J
Calonge M
Publication year
Publication venue
Investigative ophthalmology & visual science

External Links

Snippet

Purpose.: To evaluate mRNA levels of the ocular mucins MUC1, MUC2, MUC4, MUC5AC, and MUC7 in conjunctival impression cytology samples from patients with moderate to severe dry eye syndrome (DES) compared with a population of healthy subjects; and to …
Continue reading at iovs.arvojournals.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Similar Documents

Publication Publication Date Title
Corrales et al. Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome
Choquet et al. A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci
Jacobs et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria
Nishtala et al. Tear biomarkers for keratoconus
Rong et al. Genetic associations for keratoconus: a systematic review and meta-analysis
Wright et al. Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance
Vithana et al. Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma
Ma et al. Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases
Labbé et al. Tear film osmolarity in patients treated for glaucoma or ocular hypertension
Gipson et al. Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye
Ahram et al. The genetic mechanisms of primary angle closure glaucoma
Dogru et al. The effects of 2 week senofilcon—A silicone hydrogel contact lens daily wear on tear functions and ocular surface health status
Torok et al. Tear fluid proteomics multimarkers for diabetic retinopathy screening
Cocho et al. Gene Expression–Based predictive models of graft versus host Disease–Associated dry eye
Hashemi et al. Meibomian gland dysfunction and its determinants in Iranian adults: A population-based study
Hagan Biomarkers of ocular surface disease using impression cytology
Garcia et al. Comparative study of limbal stem cell deficiency diagnosis methods: detection of MUC5AC mRNA and goblet cells in corneal epithelium
Shetty et al. Characterization of corneal epithelial cells in keratoconus
López-García et al. Effects of autologous serum eye drops on conjunctival expression of MUC5AC in patients with ocular surface disorders
Ivarsdottir et al. Sequence variation at ANAPC1 accounts for 24% of the variability in corneal endothelial cell density
Park et al. Genome-wide assessment of gene-by-smoking interactions in COPD
Gerber-Hollbach et al. Tear film proteomics reveal important differences between patients with and without ocular GvHD after allogeneic hematopoietic cell transplantation
Pilson et al. miR-744-5p contributes to ocular inflammation in patients with primary Sjogrens Syndrome
Wang et al. Screening utility of a rapid non-invasive dry eye assessment algorithm
Shiraki et al. Clinical Usefulness of Monitoring Expression Levels of CCL24 (Eotaxin‐2) mRNA on the Ocular Surface in Patients with Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis